Top 4 Stocks In The Drugs Wholesale Industry With The Highest Revenue Estimates

Below are the top drugs wholesale stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.

McKesson (NYSE: MCK) is likely to post revenue of $123.73 billion in the year ending March, 2013. McKesson's PEG ratio is 1.15.

Analysts expect Cardinal Health (NYSE: CAH) to post revenue of $100.60 billion for the year ending June, 2013. Cardinal Health's trailing-twelve-month ROE is 18.35%.

AmerisourceBergen (NYSE: ABC) is expected to report revenue of $86.33 billion for the year ending September, 2013. AmerisourceBergen had $417.40 million in total cash for the latest quarter.

Omnicare (NYSE: OCR) may report revenue of $6.15 billion in the year ending December, 2013. Omnicare's trailing-twelve-month operating margin is 9.16%.